A detailed history of Gainplan LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Gainplan LLC holds 39,972 shares of WVE stock, worth $276,206. This represents 0.09% of its overall portfolio holdings.

Number of Shares
39,972
Holding current value
$276,206
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 22, 2026

BUY
$6.67 - $8.81 $266,613 - $352,153
39,972 New
39,972 $276,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $600M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Gainplan LLC Portfolio

Follow Gainplan LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gainplan LLC with notifications on news.